Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: A prospective single-center experience

Heart Rhythm

Volumn 10, Issue 12, 2013, Pages 1792-1799

  Chun, Kr Julian ^a   Bordignon, Stefano ^a   Urban, Verena ^a   Perrotta, Laura ^a   Dugo, Daniela ^a   Fürnkranz, Alexander ^a   Nowak, Bernd ^a   Schmidt, Boris ^a  

^a CARDIOANGIOLOGISCHES CENTRUM BETHANIEN   (Germany)

Author keywords

Atrial fibrillation; Left atrial appendage closure; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHENPROCOUMON;

AGED; AIR EMBOLISM; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FLUOROSCOPY; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART FAILURE; HIGH RISK PATIENT; HUMAN; LEFT ATRIAL APPENDAGE CLOSURE DEVICE; MAJOR CLINICAL STUDY; MALE; NONVALVULAR ATRIAL FIBRILLATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT DURATION; TREATMENT OUTCOME;

ACP; AF; AMPLATZER CARDIAC PLUG; ASA; ASPIRIN; ATRIAL FIBRILLATION; DPI; DUAL PLATELET INHIBITION; LA; LAA; LEFT ATRIAL APPENDAGE; LEFT ATRIAL APPENDAGE CLOSURE; LEFT ATRIUM/ATRIAL; NONVALVULAR ATRIAL FIBRILLATION; NVAF; OAC; ORAL ANTICOAGULATION; PERCUTANEOUS CLOSURE OF THE LEFT ATRIAL APPENDAGE VERSUS WARFARIN THERAPY FOR PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION; PROTECT-AF; STROKE; TEE; TIA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; VITAMIN K ANTAGONIST; VKA;

AGED; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; STROKE; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84889878928     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2013.08.025     Document Type: Article

References (20)

1. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
2. A.J. Camm, P. Kirchhof, and G.Y. Lip Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
3. T.J. Bungard, W.A. Ghali, K.K. Teo, F.A. McAlister, and R.T. Tsuyuki Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 160 2000 41 46
4. H. Aberg Atrial fibrillation. I. A study of atrial thrombosis and systemic embolism in a necropsy material Acta Med Scand 185 1969 373 379
5. S.H. Ostermayer, M. Reisman, and P.H. Kramer Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials J Am Coll Cardiol 46 2005 9 14
6. D.R. Holmes, V.Y. Reddy, and Z.G. Turi Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial Lancet 374 2009 534 542
7. A.J. Camm, G.Y. Lip, and R. De Caterina 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association Eur Heart J. 33 21 2012 Nov 2719 2747
8. M. Urena, J. Rodes-Cabau, and X. Freixa Percutaneous left atrial appendage closure with the Amplatzer cardiac plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy J Am Coll Cardiol. 62 2 2013 Jul 9 96 102
9. J.W. Park, A. Bethencourt, and H. Sievert Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience Catheter Cardiovasc Interv 77 2011 700 706
10. Y.Y. Lam, G.W. Yip, and C.M. Yu Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience Catheter Cardiovasc Interv 79 2012 794 800
11. H. Sievert, M.D. Lesh, and T. Trepels Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience Circulation 105 2002 1887 1889
12. L. Di Biase, P. Santangeli, and M. Anselmino Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study J Am Coll Cardiol 60 2012 531 538
13. N.M. Al-Saady, O.A. Obel, and A.J. Camm Left atrial appendage: structure, function, and role in thromboembolism Heart 82 1999 547 554
14. V.Y. Reddy, D. Holmes, S.K. Doshi, P. Neuzil, and S. Kar Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry Circulation 123 2011 417 424
15. J.F. Viles-Gonzalez, S. Kar, and P. Douglas The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy J Am Coll Cardiol 59 2012 923 929
16. V.Y. Reddy, S. Mobius-Winkler, and M.A. Miller Left atrial appendage closure with the watchman device in patients with a contraindication for oral anticoagulation: ASA Plavix Feasibility Study with Watchman Left Atrial Appendage Closure Technology (ASAP Study) J Am Coll Cardiol. 61 25 2013 Jun 25 2551 2556
17. E.E. Guerios, M. Schmid, and S. Gloekler Left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation Arq Bras Cardiol 98 2012 528 536
18. M.B. Leon, D.S. Baim, and J.J. Popma Stent Anticoagulation Restenosis Study Investigators. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting N Engl J Med 339 1998 1665 1671
19. S.J. Connolly, M.D. Ezekowitz, and S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
20. S.R. Gangireddy, J.L. Halperin, V. Fuster, and V.Y. Reddy Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit Eur Heart J 33 2012 2700 2708